United States· US:62742-4237_0bc829ff-34a1-03e9-e063-6294a90a10ae
Sea Clearly Hydrating Facial SPF 35 Kinetin
A medicinal product containing octisalate; octocrylene; homosalate; avobenzone, registered in United States by Allure Labs.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTISALATE; OCTOCRYLENE; HOMOSALATE; AVOBENZONE
- Manufacturer
- Allure Labs
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1162742-4237-1
- ndc11627424237150 g in 1 BOTTLE, PUMP (62742-4237-1)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/10d19508-dbe1-4535-8eae-a15ad45ea311 GET /v1/drugs/10d19508-dbe1-4535-8eae-a15ad45ea311?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "5; 10; 5; 2.5",
"substance": "OCTISALATE; OCTOCRYLENE; HOMOSALATE; AVOBENZONE",
"productndc": "62742-4237",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/100g; g/100g; g/100g; g/100g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octisalate; octocrylene; homosalate; avobenzone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.